Zobrazeno 1 - 10
of 82
pro vyhledávání: '"J van der Stok"'
Publikováno v:
European Cells & Materials, Vol 38, Pp 94-105 (2019)
This study aimed at investigating in vitro and in vivo the efficiency of commercially available fibrin as a carrier for controlled and sustained bone morphogenetic protein-2 (BMP-2) release to induce bone formation and reduce the side effects of its
Externí odkaz:
https://doaj.org/article/4447fed56ae94c74b991a93aafe25d4b
Autor:
J van der Stok, MKE Koolen, MPM de Maat, S Amin Yavari, J Alblas, P Patka, JAN Verhaar, EMM van Lieshout, AA Zadpoor, H Weinans, H Jahr
Publikováno v:
European Cells & Materials, Vol 29, Pp 141-154 (2015)
Regeneration of load-bearing segmental bone defects is a major challenge in trauma and orthopaedic surgery. The ideal bone graft substitute is a biomaterial that provides immediate mechanical stability, while stimulating bone regeneration to complete
Externí odkaz:
https://doaj.org/article/319d9245a17144d4a69a8825d771d6fe
Autor:
MT Poldervaart, J van der Stok, MFP de Haas, MC ‘t Hart, FC Öner, WJA Dhert, H Weinans, J Alblas
Publikováno v:
European Cells & Materials, Vol 29, Pp 35-41 (2015)
Treatment of large bone defects is currently performed using mainly autograft or allograft bone. There are important drawbacks to bone grafting, such as limited availability, donor site morbidity in the case of autograft and inferior performance of a
Externí odkaz:
https://doaj.org/article/d35a21b272d0485b96d9e76e12c44f6e
Publikováno v:
European Cells & Materials, Vol 27, Pp 137-148 (2014)
Grafting bone defects or atrophic non-unions with mesenchymal stromal cells (MSCs)-based grafts is not yet successful. MSC-based grafts typically use undifferentiated or osteogenically differentiated MSCs and regenerate bone through intramembranous o
Externí odkaz:
https://doaj.org/article/d2e26d6e6c8d40de956777fb067a98e6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jérôme Cornette, Catharina J. van der Stok, Irwin K. M. Reiss, René F. Kornelisse, Eline van der Wilk, Arie Franx, Yves Jacquemyn, Eric A. P. Steegers, Loes C. M. Bertens
Publikováno v:
Acta obstetricia et gynecologica Scandinavica
Acta Obstetricia et Gynecologica Scandinavica, 102(1), 82-91. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 102(1), 82-91. Wiley-Blackwell
Introduction Human pregnancy is considered term from 37+0/7 to 41+6/7 weeks. Within this range, both maternal, fetal and neonatal risks may vary considerably. This study investigates how gestational age per week is related to the components of perina
Autor:
Harrie Weinans, Marianne K. E. Koolen, Alessia Longoni, Debby Gawlitta, J. van der Stok, O. P. van der Jagt
Publikováno v:
European cells & materials, 38, 94-105. AO Research Institute
European Cells & Materials, 38, 94. Swiss Society for Biomaterials
European Cells & Materials, Vol 38, Pp 94-105 (2019)
European Cells & Materials, 38, 94. Swiss Society for Biomaterials
European Cells & Materials, Vol 38, Pp 94-105 (2019)
This study aimed at investigating in vitro and in vivo the efficiency of commercially available fibrin as a carrier for controlled and sustained bone morphogenetic protein-2 (BMP-2) release to induce bone formation and reduce the side effects of its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9071cba49edb7d5acdbfd533b1d229b
https://dspace.library.uu.nl/handle/1874/388544
https://dspace.library.uu.nl/handle/1874/388544
Autor:
J., Cornette, C. J., van der Stok, I. K. M., Reiss, R. F., Kornelisse, E., van der Wilk, A., Franx, Y., Jacquemyn, E. A. P., Steegers, L. C. M., Bertens
Publikováno v:
Obstetric Anesthesia Digest; Dec2023, Vol. 43 Issue 4, p189-190, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Bone & Joint Research
Objectives The aim of this systematic literature review was to assess the clinical level of evidence of commercially available demineralised bone matrix (DBM) products for their use in trauma and orthopaedic related surgery. Methods A total of 17 DBM